| Laura Hulsey Lidji, SLP | |
|
2644 Riva Rd, Annapolis, MD 21401-7427 | |
| (410) 222-5000 | |
| Not Available |
| Full Name | Laura Hulsey Lidji |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2644 Riva Rd, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770760092 | NPI | - | NPPES |
| 6516 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 05653 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Hulsey Lidji, SLP 2644 Riva Rd, Annapolis, MD 21401-7427 Ph: (410) 222-5000 | Laura Hulsey Lidji, SLP 2644 Riva Rd, Annapolis, MD 21401-7427 Ph: (410) 222-5000 |
News Archive
Science fiction novelist and scholar Issac Asimov once said, "The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny.' " This recently rang true for an international team of researchers when they observed something they did not expect.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Two Massachusetts General Hospital physicians who participated in the international response to the major earthquakes that hit Nepal in April and May each describe their experiences in Perspectives articles receiving Online First publication today in the New England Journal of Medicine.
Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.
Researchers from the School of Immunology & Microbial Sciences have engineered a novel way of delivering gene therapy that they hope will mean scientists and doctors can target areas of the brain that were previously difficult to reach.
› Verified 9 days ago
Fran L Silverman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Anne Caverly, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Taylor Falatach, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Williams Dr, Annapolis, MD 21401 Phone: 609-519-1954 | |
Mrs. Betty Chan-brown, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411 Fax: 410-571-6415 | |
Mrs. Judith Ann Wildner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Rajavi Sanghavi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Van Buren St, Annapolis, MD 21403 Phone: 410-267-8653 Fax: 877-828-2060 | |
Victoria Washington-harper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 |